Histamine in diabetes: is it time to reconsider?

Pini, A.; Obara, I.; Battell, E.; Chazot, P.L.; Rosa, A.C.

Abstract

The first studies of histamine and diabetes date back to the 1950s. Since that time the involvement of histamine in diabetes was related to its well known vasoactive properties and permeability leakage effects. In particular, the first evidence for a correlation between histamine and diabetes arose in 1989 when an increase in plasma and leucocyte histamine content was observed. Limited independent evidence followed in the subsequent two decades, focusing on both histamine glyceamic control and macro- and microvascular complications of diabetes. However, recent observations have sparked the question whether it is time to reconsider the functional contribution of histamine in diabetes. We reveal an interesting upsurge in the field which provides scope for new insights into the role of histamine in diabetes.

Citation

Pini, A., Obara, I., Battell, E., Chazot, P., & Rosa, A. (2016). Histamine in diabetes: is it time to reconsider?. Pharmacological Research, 111, 316-324. https://doi.org/10.1016/j.phrs.2016.06.021

• Journal Article Type: Article
• Acceptance Date: Jun 21, 2016
• Online Publication Date: Jun 22, 2016
• Publication Date: Sep 1, 2016
• Deposit Date: Jul 4, 2016
• Publicly Available Date: Jun 22, 2017
• Journal: Pharmacological Research
• Print ISSN: 1043-6618
• Publisher: Elsevier
• Peer Reviewed: Peer Reviewed
• Volume: 111
• Pages: 316-324
• DOI: https://doi.org/10.1016/j.phrs.2016.06.021